The effects of vascular endothelial growth factor C knockdown in esophageal squamous cell carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 1, 2012, Pages 133-139

  Zhang, Hongxin ^a   Yin, Yuhui ^a   Zhang, Lan ^a   Zheng, Xiangyu ^a   Gao, Dongling ^a   Chen, Kuisheng ^a   Zhang, Yunhan ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Esophageal neoplasm; Nude mice; RT PCR; Short interfering RNA; Vascular endothelial growth factor C

Indexed keywords

MESSENGER RNA; PLASMID VECTOR; SMALL INTERFERING RNA; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER TRANSPLANTATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE EXPRESSION REGULATION; GENE LOCATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR C GENE; WESTERN BLOTTING;

ADULT; AGED; ANIMALS; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; PLASMIDS; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84857046491     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1079-9     Document Type: Article

References (20)

1. Ashihara E, Kawata E et al (2010) Future prospect of RNA interference for cancer therapies. Curr Drug Targets 11:345-360
2. Brummelkamp TR, Bernards R et al (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550-553 (Pubitemid 34408678)
3. Elbashir SM, Harborth J et al (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494-498 (Pubitemid 32494397)
4. Elbashir SM, Harborth J et al (2002) Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods: 26:199-213 (Pubitemid 34969582)
5. Gotoh H, Kanomata N et al (2009) Morphometric analysis of regional lymph nodes in surgically resected non-small cell lung cancer. Med Mol Morphol 42:162-166
6. Haussecker D, Huang Y et al (2010) Human tRNA-derived small RNAs in the global regulation of RNA silencing. RNA 16:673-695
7. Joukov V, Pajusola K et al (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290-298 (Pubitemid 26029207)
8. Kodama M, Kitadai Y et al (2008) Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Clin Cancer Res 14:7205-7214
9. McCarter MD, Clarke JH et al (2004) Lymphangiogenesis is pivotal to the trials of a successful cancer metastasis. Surgery 135:121-124 (Pubitemid 38130761)
10. Nathanson SD (2003) Insights into the mechanisms of lymph node metastasis. Cancer 98:413-423 (Pubitemid 36828469)
11. Paavonen K, Horelli-Kuitunen N et al (1996) Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation 93:1079-1082 (Pubitemid 26089805)
12. Paramo JC, Summerall J et al (2002) Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol 9:550-554 (Pubitemid 34774415)
13. Pisani P, Parkin DM et al (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18-29 (Pubitemid 29409471)
14. Song-liang Q, Guan-rui Y (1988) Precursor lesions of esophageal cancer in high-risk populations in Henan Province, China. Cancer 62:551-557
15. Stacker SA, Achen MG (2008) From anti-angiogenesis to antilymphangiogenesis: emerging trends in cancer therapy. Lymphatic Res Biol 6:165-172
16. Subramanya S, Kim SS et al (2010) RNA interference-based therapeutics for human immunodeficiency virus HIV-1 treatment: synthetic siRNA or vector-based shRNA? Expert Opinion Biol Therapy 10:201-213
17. Tammela T, Petrova TV et al (2005) Molecular lymphangiogenesis: new players. Trends Cell Biol 15:434-441 (Pubitemid 41125775)
18. Vrekoussis T, Chaniotis V et al (2009) Image analysis of breast cancer immunohistochemistry-stained sections using image: an RGB-based model. J Anticancer Res 29:4995-4998
19. Wilson R, Purcell D et al (2009) Does RNA interference provide new hope for control of chronic hepatitis B infection. Antivir Ther 14:879-889
20. Xing-e L, Xiao-dong S et al (2004) Expression and significance of VEGF-C and FLT-4 in gastric cancer. World J Gastroenterol 10:352-355